INC.;EPIZYME, INC.;GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED;EPIZYME
发明人:
DUNCAN, KENNETH W.,CHESWORTH, RICHARD,BORIACK-SJODIN, PAULA ANN,MUNCHHOF, MICHAEL JOHN,JIN, LEI,PENEBRE, ELAYNE,BARBASH, OLENA I.
申请号：
CA2953572
公开号：
CA2953572A1
申请日:
2015.08.04
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
Described herein are methods of treating cancer using one or more PRMT5 inhibitors, for example using one or more compounds of Formulae (1-5) or (A-F), pharmaceutically acceptable salts thereof, and/or pharmaceutical compositions thereof. Described herein are methods of treating cancer using one or more PRMT5 inhibitors, for example using one or more compounds of Formulae (1-5) or (A-F), pharmaceutically acceptable salts thereof, and/or pharmaceutical compositions thereof.
